Mondrian Investment Partners’s Omega Protein OME Stock Holding History

Mondrian Investment Partners’s Portfolio OME Stock Details OME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-279,803	Closed	-$4.66M	–	143
2017 Q3	$4.66M	Buy	279,803 +35,699	+15%	+$580K	0.12%	51
2017 Q2	$4.37M	Buy	244,104 +20,218	+9%	+$378K	0.13%	51
2017 Q1	$4.49M	Buy	223,886 +37,010	+20%	+$862K	0.13%	54
2016 Q4	$4.68M	Buy	186,876 +21,789	+13%	+$515K	0.14%	56
2016 Q3	$3.86M	Sell	165,087 -48,177	-23%	-$1.13M	0.09%	69
2016 Q2	$4.26M	Hold	213,264	–	–	0.1%	61
2016 Q1	$3.61M	Buy	213,264 +211,082	+9,674%	+$4.33M	0.08%	70
2015 Q4	$48K	Hold	2,182	–	–	﹤0.01%	88
2015 Q3	$37K	Buy	+2,182	New	+$34K	﹤0.01%	101

Mondrian Investment Partners's OME Position: Q4 2017 in Review

Mondrian Investment Partners sold out of Omega Protein (OME) in Q4 2017, closing a stake of 279,803 shares — an estimated $4.66M sold.

Mondrian Investment Partners first reported a position in OME in Q3 2015 and held it in 9 quarters. The position peaked at $4.68M in Q4 2016. 0 funds tracked by Wall St. Rank hold OME as of Q4 2017.

Mondrian Investment Partners reported no remaining Omega Protein position as of Q4 2017 after selling out during the quarter.
Mondrian Investment Partners sold 279,803 Omega Protein shares in Q4 2017, an estimated $4.66M.
Mondrian Investment Partners first reported a position in Omega Protein in Q3 2015 and held it in 9 quarters.
Mondrian Investment Partners's Omega Protein position peaked at $4.68M in Q4 2016.
0 funds tracked by Wall St. Rank held Omega Protein as of Q4 2017.

Based on Mondrian Investment Partners's 13F filing for Q4 2017, filed 18 Jan 2018.